leadf
logo-loader
viewLexaGene Holdings Inc.
(
TSX-V:LXGOTCQB:LXXGF
)

LexaGene MiQLab on display as the company highlights unique features at WVC conference in Las Vegas

LexaGene CEO Dr. Jack Regan joined Steve Darling from Proactive on the floor of the 93rd annual WVC conference. This conference in Las Vegas is a gathering of veterinary marketplace leaders.

Regan, who is a highlight speaker at the event, shared more with Proactive about his topic “In-Clinic PCR Testing for Pathogen ID and Antibiotic Resistance Detection”. He also talked about the reaction from those coming by their booth asking about the MiQLab.

Quick facts: LexaGene Holdings Inc.

Follow
TSX-V:LXG

Price: 0.43 CAD

Market Cap: $51.12 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...

FOR OUR FULL DISCLAIMER CLICK HERE

LexaGene MiQLab has successfully detected Polymicrobial Samples missed in...

LexaGene Holding CEO Dr. Jack Regan joined Steve Darling from Proactive to share news their MiQLab System has been able to detect multiple strains of pathogenic bacteria in polymicrobial samples that vary in their antimicrobial resistance. Regan telling Proactive these samples were missed by...

2 weeks ago

2 min read